Depemokimab, the first ultra-long-acting anti-IL-5 monoclonal antibody for severe eosinophilic asthma
Santi Nolasco, Claudia Crimi
Topics & Concepts
Monoclonal antibodyEosinophilicAsthmaMedicineMepolizumabImmunologyAntibodyPathologyEosinophilAsthma and respiratory diseasesEosinophilic EsophagitisIL-33, ST2, and ILC Pathways